Amgen EVP has 1,257 shares withheld for taxes
Amgen Inc. executive vice president and general counsel Jonathan P. Graham reported two routine tax-related share dispositions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amgen Inc. executive vice president and general counsel Jonathan P. Graham reported two routine tax-related share dispositions. On May 2, 2026, a total of 1,257 shares of Amgen common stock were withheld at $329.82 per share to satisfy tax obligations on equity awards, rather than sold on the open market. Following these transactions, his reported direct holdings in the affected accounts were 38,010 and 38,620 shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 647 | $329.82 | $213K |
| Exercise Price or Tax Liability | Common Stock | 610 | $329.82 | $201K |
Footnotes (1)
- F1. These shares include 395 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
Key Terms
tax-withholding disposition financial
Restricted Stock Units financial
Dividend Equivalents financial
Equity Incentive Plan financial
dividend reinvestment plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amgen (AMGN) executive Jonathan P. Graham report in this Form 4 filing?
Were Jonathan P. Graham’s Amgen (AMGN) transactions open-market sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.